Dual Antiplatelet Therapy and Heparin “Bridging” Significantly Increase the Risk of Bleeding Complications After Pacemaker or Implantable Cardioverter-Defibrillator Device Implantation
Year: 2010
Type: article
Study design: Observational Study
Institutions: Johns Hopkins University, Johns Hopkins Hospital
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: Medtronic, Boston Scientific Corporation
OpenAlex ID: W2066546503
